Changes to the Meningococcal C conjugate (MenC) vaccine schedule 2013 Q&As for healthcare practitioners

Studies show that vaccination against meningococcal C (MenC) disease in early childhood provides a relatively short-term protective immune response. Protection given by vaccination at 12 months wanes by the teenage years, but vaccination later in childhood provides higher levels of antibody that persist for longer. This document summarises the changes to the schedule, and addresses likely technical questions about making the changes work in practice.